<code id='D8878F0793'></code><style id='D8878F0793'></style>
    • <acronym id='D8878F0793'></acronym>
      <center id='D8878F0793'><center id='D8878F0793'><tfoot id='D8878F0793'></tfoot></center><abbr id='D8878F0793'><dir id='D8878F0793'><tfoot id='D8878F0793'></tfoot><noframes id='D8878F0793'>

    • <optgroup id='D8878F0793'><strike id='D8878F0793'><sup id='D8878F0793'></sup></strike><code id='D8878F0793'></code></optgroup>
        1. <b id='D8878F0793'><label id='D8878F0793'><select id='D8878F0793'><dt id='D8878F0793'><span id='D8878F0793'></span></dt></select></label></b><u id='D8878F0793'></u>
          <i id='D8878F0793'><strike id='D8878F0793'><tt id='D8878F0793'><pre id='D8878F0793'></pre></tt></strike></i>

          comprehensive

          explore

          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more
          Patient advocates debate FDA's accelerated approval process
          Patient advocates debate FDA's accelerated approval process

          Fromleft,STAT'sAllisonDeAngelis,ALSadvocateCathyCollet,Yale'sGreggGonsalves,SickCells'AshleyValentin

          read more
          In age of alternative facts, a scholarly course on calling out crap
          In age of alternative facts, a scholarly course on calling out crap

          Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

          read more

          FDA's naming rule on biosimilars has undermined competition

          AdobeIrecentlytriedtoorderwhitebloodcellgrowthfactor(pegfilgrastim)biosimilarforoneofmypatients.This